Margitta Gummel’s rise from a consistent 17-metre shot putter to Olympic champion became one of the clearest documented examples of East Germany’s early anabolic-steroid program. According to records later reproduced from a 1973 East German scientific report in a 1997 Clinical Chemistry paper, Gummel received her first dose of Oral-Turinabol on 28 July 1968, less than three months before the Mexico City Olympics. She was reportedly given only 10 milligrams per day, yet her competition distances climbed by roughly two metres during that short cycle—from about 17 metres to more than 19. At Mexico City, she won the gold medal and became the first woman to surpass 19 metres in the shot put, a dramatic improvement that the surviving charts contrasted with her previously stable performances.
The records also tracked later steroid cycles in 1969 and 1972, showing higher dosages and throws that eventually exceeded 20 metres. East German researchers treated Gummel not simply as an athlete but as data in an experiment: their charts suggested that performance remained substantially elevated even during drug-free intervals, a residual effect they attributed to repeated steroid use. The episode was particularly disturbing because the same state-backed research drew conclusions that anabolic steroids could produce gains far beyond those achieved through natural training, helping justify the later administration of Turinabol to much younger female athletes, including girls around 13 or 14 in sports such as swimming. Gummel’s medals were not stripped in the historical account provided, but the documentation permanently complicated her Olympic legacy and exposed how East Germany’s sporting success was tied to a systematic, scientifically monitored doping regime.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.
AI concept artwork · not archival photography